|4/AJan 20, 2:24 PM ET

Huber Reid M 4/A

4/A · BELLICUM PHARMACEUTICALS, INC · Filed Jan 20, 2023

Insider Transaction Report

Form 4/AAmended
Period: 2023-01-03
Huber Reid M
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2023-01-03+80,968146,951 total
Footnotes (1)
  • [F1]This amendment is being filed to correct the mathematical error in the amount of securities acquired and the amount of securities beneficially owned following reported transaction on the original Form 4 filed with the SEC on January 5, 2023.

Documents

1 file
  • 4
    wf-form4a_167424267625682.xml

    FORM 4/A